Recurrent Respiratory Papillomatosis
2 competing products in clinical development for Recurrent Respiratory Papillomatosis.
Pipeline by Phase
Phase 1/21
Approved1
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Zopapogene imadenovec (Zopa) | Precigen | Approved | Recruiting | 80 |
| PRGN-2012 - Phase I; Dose Level 1 + PRGN-2012 - Phase I; Dose Level 2 + PRGN-2012 - Phase II; Dose Level 2 | Precigen | Phase 1/2 | Active | 36 |